Becton Dickinson's (NYSE:BDX) stock is up by 4.3% over the past month. As most would know, long-term fundamentals have a strong correlation with market price movements, so we decided to look at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science ...

Becton, Dickinson and Company is rated a hold due to low growth, valuation concerns, and underperformance compared to healthcare equipment peers. BDX's acquisition of Edwards Lifesciences ...

Becton, Dickinson & Co. is investing more than $30 million to boost its U.S. manufacturing of intravenous catheters. The additional production lines at its plant in Sandy, Utah, follows previous ...

Ex-scientist allegedly obtained trade secrets before leaving Court order prohibits her from disclosing to third parties Becton, Dickinson and Co. notched a court order prohibiting one of its former ...

Becton Dickinson (NYSE:BDX) said it plans to make additional investments in its U.S. manufacturing network to add capacity for the production of critical medical devices such as syringes ...